The Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling is a novel joint initiative in Germany between the Freie Universität Berlin and the Universität Potsdam, supported by the research-driven pharmaceutical companies AbbVie Deutschland GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, F. Hoffmann-La Roche Ltd, Grünenthal GmbH, Merck KGaA and SANOFI.

It offers its graduate students a unique opportunity to experience research in the area of drug development and optimising drug therapy jointly within academia and industry.

The interdisciplinary PhD program is designed as a 3.5-year research program including a structured research training curriculum of advanced academic & industrial modules and a competitive research fellowship.